CNBX Pharmaceuticals Inc. (CNBX): Operating Income
-$271.7K
Year ended 2025-08-31
-$429.5K
Trailing 12 months to 2026-05-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-08-31 | -$271.7K | n/m | 2025-12-01, From 2024-09-01 |
| 2024-08-31 | -$583.1K | n/m | 2025-12-01, From 2023-09-01 |
| 2023-08-31 | -$931.4K | n/m | 2024-11-29, From 2022-09-01 |
| 2022-08-31 | -$2.95M | n/m | 2023-11-30, From 2021-09-01 |
| 2021-08-31 | -$2.60M | n/m | 2022-11-30, From 2020-09-01 |
| 2020-08-31 | -$3.04M | n/m | 2021-11-29, From 2019-09-01 |
| 2019-08-31 | -$3.30M | n/m | 2020-11-04, From 2018-09-01 |
| 2018-08-31 | -$3.81M | n/m | 2019-11-29, From 2017-09-01 |
| 2017-08-31 | -$1.85M | n/m | 2018-11-29, From 2016-09-01 |
| 2016-08-31 | -$280.7K | n/m | 2017-12-08, From 2015-09-01 |
| 2015-08-31 | -$536.5K | n/m | 2016-12-13, From 2014-09-01 |
| 2014-08-31 | -$216.1K | n/m | 2016-01-07, From 2013-09-01 |
| 2013-08-31 | -$58.1K | n/a | 2015-10-23, From 2012-09-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| CNBX Pharmaceuticals Inc. (CNBX) | 2025-08-31 | -$271.7K | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $8.05B | +18.0% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$4.39M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $24.74M | +23.1% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$5.29M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$18.21M | n/m |
| Procyon Corp (PCYN) | 2024-06-30 | -$231.7K | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$2.54M | n/m |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $2.16B | n/m |
Compare CNBX, ABT, TXMD, NATR side by side · Screen every company in Pharmaceutical Preparations ↗